The U.S. House of Representatives votes to fund the FDA until the federal shutdown ends, or until Dec. 15, whichever comes first.
The U.S. House of Representatives voted tonight to fund the FDA until the federal shutdown ends or until Dec. 15, whichever comes first.
The lower chamber approved on a 235-162 vote a joint resolution by Rep. Robert Aderholt (R-Ala.) that restores funding to the level established by sequestration, which is about $200 million less than originally authorized.
The measure is unlikely to pass muster in the Senate, where majority leader Sen. Harry Reid (D-Nev.) has vowed to shoot down any proposed stop-gap funding legislation.
The vote capped the 7th day of the federal shutdown, begun Oct. 1 when the Senate nixed a continuing resolution after the House added a pair of provisions that would have repealed the medical device tax and delayed the implementation of Obamacare's insurance exchanges by a year.
Aderholt, who is chairman of the House Agriculture Appropriations Subcommittee, said FDA funding bill would also allow the watchdog agency to collect the user fees that industry pays to have its medical device and drugs reviewed.
"It is now time for this body to continue funding 1 more critical component of our public health infrastructure," Aderholt said. "We need the entire agency back at work."
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...